AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionJB Capital LLC
Latest Disclosed Ownership11,280 shares
Latest Disclosed Value $ 2,453,295
JB Capital LLC reports 33.31% decrease in ownership of 4AB / AbbVie Inc.

On April 27, 2026 - JB Capital LLC filed a 13F-HR form disclosing ownership of 11,280 shares of AbbVie Inc. (BG:4AB) valued at $2,453,295 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 16,913 shares of AbbVie Inc.. This represents a change in shares of -33.31% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F ABBVIE COM 00287Y109 11,280 -5,633 -33.31 2,453 -36.52 0.0991
2026-01-20 2025-12-31 13F ABBVIE COM 00287Y109 16,913 12,338 269.68 3,864 264.87 0.1577
2025-10-20 2025-09-30 13F ABBVIE COM 00287Y109 4,575 20 0.44 1,059 25.33 0.0457
2025-07-24 2025-06-30 13F ABBVIE COM 00287Y109 4,555 -49 -1.06 846 -12.34 0.0410
2025-04-23 2025-03-31 13F ABBVIE COM 00287Y109 4,604 385 9.13 965 28.70 0.0532
2025-01-24 2024-12-31 13F ABBVIE COM 00287Y109 4,219 -109 -2.52 750 -12.30 0.0420
2024-10-31 2024-09-30 13F ABBVIE COM 00287Y109 4,328 -560 -11.46 855 1.91 0.0491
2024-07-24 2024-06-30 13F ABBVIE COM 00287Y109 4,888 36 0.74 839 -5.10 0.0525
2024-04-30 2024-03-31 13F ABBVIE COM 00287Y109 4,852 119 2.51 884 20.46 0.0588
2024-01-22 2023-12-31 13F ABBVIE COM 00287Y109 4,733 275 6.17 733 10.39 0.0541
2023-10-25 2023-09-30 13F ABBVIE COM 00287Y109 4,458 -156 -3.38 665 6.92 0.0561
2023-07-25 2023-06-30 13F ABBVIE COM 00287Y109 4,614 -128 -2.70 622 -17.75 0.0525
2023-04-25 2023-03-31 13F ABBVIE COM 00287Y109 4,742 -166 -3.38 756 -4.79 0.0690
2023-01-23 2022-12-31 13F ABBVIE COM 00287Y109 4,908 -164 -3.23 793 16.45 0.0776
2022-10-14 2022-09-30 13F ABBVIE COM 00287Y109 5,072 -28,458 -84.87 681 -86.74 0.0748
2022-07-28 2022-06-30 13F AbbVie COM 00287Y109 33,530 -17,601 -34.42 5,135 -38.05 0.5508
2022-04-19 2022-03-31 13F AbbVie COM 00287Y109 51,131 -1,883 -3.55 8,289 -99.88 0.8067
2022-02-02 2021-12-31 13F AbbVie SHS 00287Y109 53,014 2,889 5.76 7,178,140 132,656.43 0.7022
2021-12-08 2021-09-30 13F AbbVie COMMON STOCK 00287Y109 50,125 50,125 5,407 0.6997
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.